Specific immunotherapy of both adoptive T cell therapy and cancer vaccine involves in CD8+ CTL induction in vitro or in vivo by antigen stimulation, which is one of the key factors affecting immunotherapy effects. This evidence concerns the gene CD8A and cancer.